GLOW
Skin and recovery blend
Also known as The GLOW blend
- Evidence grade
- DNo completed human trialsScale
- Schedule
- Once daily, subcutaneous
- Maintenance amount
- 300 mcg
- Vial sizes sold
- 70 mg
Where a value is not established in people, this table says so rather than filling the box.
GLOW is a popular blend of GHK-Cu, BPC-157 and TB-500, combining a skin-and-collagen copper peptide with two repair peptides. It is marketed for skin quality alongside recovery.
GLOW pairs GHK-Cu, studied for skin renewal and collagen, with BPC-157 and TB-500, studied for tissue repair and blood-vessel growth. The idea is to support skin, hair and healing at the same time from one vial. There are no trials on the blend itself, only on the individual components, mostly in early research. See the component pages for the underlying detail.
There are no trials on the GLOW blend itself. The evidence below is for its components, studied separately, mostly in early research.
- GHK-Cu studied for skin firmness, collagen and wound healing
- BPC-157 studied for tendon, gut and muscle repair
- TB-500 studied for wound healing and new blood-vessel growth
- Combined for skin quality alongside general recovery
- No human safety data on the blend, and the repair components lack completed human trials
- Possible injection-site reactions
- Blood-vessel-promoting activity raises a theoretical tumor-growth concern
- Unregulated products vary in purity and ratio
A summary of the research, not medical advice. Individual benefits and risks vary, and for some of these compounds the human evidence is still early.
GLOW combines GHK-Cu, BPC-157 and TB-500, so its reported timeline is really the overlap of three separate ones. Skin and collagen-related changes are generally reported slower than the repair-focused changes from the BPC-157 and TB-500 components.
Read the full timeline →Drawn from published trial data and how the research community commonly describes this stretch. Not a fixed schedule and not medical advice.
Once daily, subcutaneous. For research reference only, not medical advice.
| Phase | Amount |
|---|---|
| Ongoing | one daily dose of the blend |
Dosed as a blend. Follow the component amounts on their pages.
Lyophilized: Keep the sealed powder cold and dark, near -20 °C, dry and out of light.
Reconstituted: Refrigerate the mixed vial at 2 to 8 °C, use within a few weeks and avoid freeze and thaw.
Let a cold vial reach room temperature before you open it, so it takes on less condensation.
How strong is the evidence for GLOW?
We grade it D on a four-point scale. No trials on the blend. Its components are studied separately, mostly in early research.
What amount of GLOW is used in the research?
Ongoing: one daily dose of the blend. Dosed as a blend. Follow the component amounts on their pages.
How is GLOW stored once reconstituted?
Refrigerate the mixed vial at 2 to 8 °C, use within a few weeks and avoid freeze and thaw.